Genky DrugStores Co., Ltd. (TYO:9267)

Genky DrugStores Balance Sheet

Financials in millions JPY. Fiscal year is July - June.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 20, 2026	Jun 20, 2026	Jun 20, 2025	Jun 20, 2024	Jun 20, 2023	Jun 20, 2022
Cash & Equivalents	13,928	7,866	6,221	5,896	5,329	5,438
Cash & Short-Term Investments	13,928	7,866	6,221	5,896	5,329	5,438
Cash Growth	24.05%	26.44%	5.51%	10.64%	-2.00%	-31.28%
Accounts Receivable	5,901	5,667	4,837	4,685	3,925	2,799
Other Receivables	-	3,413	2,575	2,406	2,259	2,014
Receivables	5,901	9,080	7,412	7,091	6,184	4,813
Inventory	28,092	28,654	27,071	24,028	22,490	20,911
Other Current Assets	3,892	521	506	319	410	352
Total Current Assets	51,813	46,121	41,210	37,334	34,413	31,514
Property, Plant & Equipment	93,362	91,869	79,203	69,936	65,104	59,260
Long-Term Investments	7,398	4,363	3,857	3,760	3,637	3,680
Other Intangible Assets	269	266	307	378	363	374
Long-Term Deferred Tax Assets	-	2,376	2,120	2,039	1,840	1,698
Other Long-Term Assets	2	1	2	2	1	1
Total Assets	152,844	145,598	127,326	113,939	105,912	97,118

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 20, 2026	Jun 20, 2026	Jun 20, 2025	Jun 20, 2024	Jun 20, 2023	Jun 20, 2022
Accounts Payable	36,651	30,854	26,732	24,188	22,192	20,564
Accrued Expenses	442	103	121	133	136	105
Current Portion of Long-Term Debt	9,738	9,481	8,412	8,088	11,242	10,180
Current Portion of Leases	-	6	6	7	19	17
Current Income Taxes Payable	941	7,479	7,132	6,939	5,467	5,594
Other Current Liabilities	6,743	1,786	1,409	1,491	1,060	1,187
Total Current Liabilities	54,515	49,709	43,812	40,846	40,116	37,647
Long-Term Debt	30,736	30,020	25,817	22,408	20,946	20,754
Long-Term Leases	-	133	139	145	147	8
Other Long-Term Liabilities	4,532	4,365	4,131	3,861	4,023	2,477
Total Liabilities	89,783	84,227	73,899	67,260	65,232	60,886

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 20, 2026	Jun 20, 2026	Jun 20, 2025	Jun 20, 2024	Jun 20, 2023	Jun 20, 2022
Common Stock	1,091	1,085	1,035	1,024	1,010	1,008
Additional Paid-In Capital	6,752	6,746	6,451	6,440	6,426	6,424
Retained Earnings	55,693	54,013	46,534	39,862	33,917	29,531
Treasury Stock	-699	-699	-790	-790	-789	-789
Comprehensive Income & Other	224	226	197	143	116	58
Shareholders' Equity	63,061	61,371	53,427	46,679	40,680	36,232
Total Liabilities & Equity	152,844	145,598	127,326	113,939	105,912	97,118

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 20, 2026	Jun 20, 2026	Jun 20, 2025	Jun 20, 2024	Jun 20, 2023	Jun 20, 2022
Total Debt	40,474	39,640	34,374	30,648	32,354	30,959
Net Cash (Debt)	-26,546	-31,774	-28,153	-24,752	-27,025	-25,521
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-868.28	-1039.73	-924.42	-813.77	-889.27	-839.63
Filing Date Shares Outstanding	30.51	30.51	30.4	30.38	30.37	30.37
Total Common Shares Outstanding	30.51	30.51	30.4	30.38	30.37	30.37
Working Capital	-2,702	-3,588	-2,602	-3,512	-5,703	-6,133
Book Value Per Share	2066.82	2011.71	1757.70	1536.31	1339.57	1193.22
Tangible Book Value	62,792	61,105	53,120	46,301	40,317	35,858
Tangible Book Value Per Share	2058.01	2002.99	1747.60	1523.87	1327.62	1180.90

Data Source: S&P Global Market Intelligence Last updated: Oct 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error